GUIDELINES FOR ORAL PAPER ABSTRACT SUBMISSION

1. Important Dates

Event	Date
Abstract Submission Opens	1st June 2026
Last Date of Abstract Submission	31st August 2026
Intimation of Acceptance / Rejection to Author	1st November 2026

2. Sub-specialties

Authors should carefully select the sub-specialty that best suits their abstract. Up to two sub-specialty categories may be selected per abstract if appropriate.

S. No.	Sub-specialty
1	Diagnostic Neuroimaging and Spine Imaging
2	Interventional Radiology – Vascular
3	Interventional Radiology – Non-vascular
4	Head and Neck, ENT, Orbits
5	Chest (Pulmonary, Chest wall, Mediastinal) Imaging
6	Breast Imaging
7	Cardiovascular Imaging
8	Gastrointestinal tract and Hepatobiliary & Pancreatic Imaging
9	Genitourinary Imaging (Renal, Urinary Tract & Male Genital Tract)
10	Gynaecological Imaging
11	Fetal Imaging
12	Musculoskeletal Imaging
13	Paediatric Imaging
14	Emergency & Trauma Imaging
15	Oncological Imaging
16	Artificial Intelligence / Technological Advances in Radiology
17	Miscellaneous

3. Oral Paper Abstract Submission Guidelines

3.1 General Requirements

• Conference registration and either life or provisional membership of IRIA is mandatory for the presenting author.
• Abstracts that have been previously published elsewhere are not eligible for submission.
• Abstracts must be submitted exclusively through the IRIA 2027 web portal at www.iria2027.com. No fax copies or e-mail submissions will be accepted.
• A presenting author may submit a maximum of 3 abstracts (including oral paper and poster abstracts).
• An abstract may only be submitted once. Duplicate abstracts (reporting the same data) submitted under a different title or authorship or subtype will not be considered.
• The first author shall be the presenting author; a maximum of 6 co-authors are permitted (mention the designation, department & the institution).
• No changes to the abstract’s content or authorship will be permitted after final submission
• Abstracts must be submitted in English only.
• The presenting author should indicate consent at the time of submission for possible conversion of the abstract category (from oral to poster or vice-versa) at the discretion of the scientific committee.

3.2 Abstract Formatting

• The abstract is limited to a maximum of 300 words (excluding title, authors, and affiliations).
• Submit abstracts as a Word document using 12-point font in Times New Roman or Arial, as specified in the web portal.
• The title should be in sentence case.
• Minimize the use of abbreviations in the body of the abstract. Provide the full expansion when an abbreviation is first used.
• References may be included in the abstract but will count towards the word limit.

3.3 Structure of the Abstract

For oral paper presentations, the abstract must be structured as follows:

• Aims and objectives
• Materials and methods
• Results
• Conclusion
• References

3.4 Originality, Copyright & Ethics

• The work must be original and unpublished. Papers / E-posters previously presented elsewhere in some other conference / forum cannot be submitted again as oral paper abstract in this conference.
• Radiological images should be from author’s own work and not copied from anywhere.
• If any material (text, graphs, charts, etc.) is borrowed from other sources, the authors must obtain appropriate permissions. Borrowed material must be clearly labelled in the slides with full citations.
• The presentation must be non-promotional and non-commercial in nature. Equipment and agents should be referred to by generic names. Commercial logos are prohibited.
• If the presentation involves off-label use of a drug, device, or technique, this must be explicitly disclosed.
• For research studies involving human subjects, a statement confirming informed consent and ethics committee / IRB approval must be included. For animal studies, compliance with NIH or equivalent institutional guidelines must be acknowledged.

3.5 AI Tools Disclosure

• The use of AI-based tools (e.g., generative AI for text, figures, schematics, flowcharts, or image processing) must be disclosed in the abstract and the oral presentation. Authors should specify which tools were used and for what purpose. Non-disclosure of such usage will lead to immediate rejection or disqualification.

3.6 Patient Confidentiality & Blinding

• The identity of the patient (name, hospital ID, or any identifying information) must not appear in any image or text. Appropriate patient consent must be obtained.
• The name or identity of the authors’ institution should not appear in any images submitted with the abstract, to maintain the integrity of the double-blind review process.

3.7 Image Quality Standards

• All images should be of high diagnostic quality.
• All images / videos should be incorporated in the powerpoint itself and set on autoplay.
• Use arrows, annotations, and labels on images where necessary to highlight key findings.

3.8 Copyright, Licensing & Withdrawal

• By submitting the abstract, the author retains copyright but grants IRIA and its academic wing ICRI a non-exclusive, royalty-free licence to present the content on the IRIA website and educational programs, and to archive it for scientific record. IRIA will not sub-licence the content to a third party.
• It is the authors’ responsibility to ensure appropriate grammar and spelling. We recommend proofreading by a colleague or use of grammar-checking tools before submission.
• All communications regarding acceptance, rejection, or change of category will be sent by email.
• Withdrawal of abstracts: Requests for withdrawal must be sent to iria2027abstract@gmail.com before the submission deadline.

3.9 Review Process

• All abstracts will be evaluated through a two-stage, double-blind peer-review process by members of the scientific committee.
• Abstracts will be judged on scientific, research, and/or clinical value, originality of work, and potential impact.
• The decision of the scientific committee (acceptance, rejection, or modification of category) will be final. No appeals will be entertained.
• Presentation is expected to reflect the contents of the accepted abstract. Substantial deviation may result in rejection of the submission as determined by the scientific committee.

3.10 Prizes & Incentives

• Selected high-quality submissions will be accepted for oral presentation.
• The top presenters will receive attractive prizes.
• The decision of the judges / organising committee regarding prizes is final.

4. Guidelines After Abstract Acceptance

• Upon acceptance, the presenting author will receive an email notification with details regarding the oral presentation guidelines and time slots.
• To withdraw your abstract after the final submission date, please inform the paper committee through iria2027abstract@gmail.com.
• Acceptance, rejection, or change of category status will be communicated through iria2027abstract@gmail.com.
• The oral presentation must be prepared in PowerPoint (.pptx) format.
• Preferred aspect ratio: 16:9 (widescreen). The system will also support 4:3.
• Videos, if any, must be integrated/embedded into the PowerPoint file.
• The inclusion of high-quality images is mandatory to illustrate findings.

5. Contact Information